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Cellular infrastructure con-
tract awards were down
somewhat in 2003 when
compared with 2002, and
less than a third of the value
of the awards recorded in
2001. In 2003, announced
infrastructure contract
awards totalled the lowest
yearly total since 1996,
notes In-Stat/MDR in its
2003 Cellular
Infrastructure Contract
Awards report.
It lists all infrastructure
awards announced in 2003,
and tabulates them by date,
award amount, technology
type/class and country.
While contract awards were
down in 2003 and 2002,
early awards in 2004 look
very promising. Much of the
shock of the W-CDMA delays
has passed, and service
providers have started to
resume their long-range plan-
ning.While 2004’s results
aren't expected to eclipse
the awards of 2001, they
should readily beat 2003’s
results and maybe 2002's
total as well.
The US and China had the
largest number and value of
contracts awarded any-
where in 2003, while
Ericsson and Nortel were
the big winners of 2003,
each getting over 20% of the
value of all contracts
announced.
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Zacks.com in mid-March
released its list of stocks that
are currently members of the
Zacks 1 Ranked list, which
have produced an average
annual return of +33.7% since
inception in 1988 and gained
+100.3% since January 2000,
when the market was in the
grips of the worst bear mar-
ket in 60 years.
KLA-Tencor Corporation’s
earnings estimates for year
ending June 2004 are up,
approximately 19c, or +21%,
from two months ago.That
includes a rise of about 3c, or
+3%, over the past 30 trading
days.
In its fiscal 2Q report from
late January, the company stat-
ed that rising chip demand
fuelled by an improving global
economy, along with high
capacity-utilisation rates, is
driving a strong upswing in
capacity-related tool orders.
Such factors helped KLA-
Tencor to post diluted earn-
ings of 22c/share in that quar-
ter, which was almost +16%
atop the consensus. Revenues
of $339m improved on both a
sequential and year-over-year
basis.
A Zacks Rank of 2 (Buy) was
given to Cree Inc, one of the
leaders in development and
manufacturing of semiconduc-
tor materials and electronic
devices made from silicon 
carbide.
In mid-January, Cree posted a
net income of 17c/diluted
share for its fiscal Q2, which
was a nickel better than the
year-ago performance and a
penny, or more than +6%, atop
the consensus.
The company said that its
record revenue and higher
profitability were driven by
strong LED sales, as it benefit-
ed from increased demand for
LEDs in mobile phone applica-
tions. Cree continued by 
Tools and SiC make the earnings grade
stating that the combination of
a favourable product mix,
reduced pricing pressure and
improved operational efficien-
cies resulted in an increase in
product gross margin, which
drove its net income for the
quarter to its highest level in
several years.
Earnings estimates for the year
ending June 2005 are up about
6c, or +10%, from levels two
months ago. Given such results,
the company now targets an
even stronger second half to
the fiscal year.
Teradyne also came in 2 rank-
ing.The largest supplier of
Automatic Test Equipment, and
a leading supplier of intercon-
nection system products,
Teradyne delivers competitive
advantage to the world’s semi-
conductor, electronics, automo-
tive and network systems 
companies. For its Q4,Teradyne
posted pro forma earnings of
4c/share in late January, on net
orders that jumped +45% to
$488.2m sequentially.
That earnings result was a
solid improvement over the
breakeven consensus expecta-
tion. Earnings estimates for
this year, ending December
2004, advanced by about 45c,
or +88%, over the past two
months.
Teradyne said that with the
momentum from its strong
over growth, along with its
cost reduction efforts, it
expects to deliver solid profit
growth in the Q1of 2004.
Since demand for its products
is strong,Teradyne could be in
line for more earnings estimate
improvement, which bodes
well for shareholders.
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